Why would anyone stay. No money to be made. Management are not transparent. BlinkRX sucks, monthly dinner programs with no value, micromanaging sample calls, should I go on?
Steve has balls and he immediately stopped all clinical and new indication spending. Money will go to the reps, access, and promo. This will turn profitable. He will bring his own team so the rest of exec will be out in no time.
Steve has balls and he immediately stopped all clinical and new indication spending. Money will go to the reps, access, and promo. This will turn profitable. He will bring his own team so the rest of exec will be out in no time.